Perforación intestinal relacionada con ipilimumab.

Bowel perforation related with ipilimumab.

Contenido principal del artículo

Andrea Robayo
Marcela Mejía
Andrés Felipe Cardona
Henry Becerra
Jorge Miguel Otero
Hernán Carranza
Carlos Vargas
Javier Carrera

Resumen

A 48-year-old man was admitted to hospital following four days of having suffered diarrhea and a febrile episode on the same day as he consulted. The diarrhea had increased to 6 episodes during the 12 hours before admission, regardless of the administration of loperamide or low doses of dexamethasone. He referred to no other symptoms upon admission.

Detalles del artículo

Biografía del autor/a (VER)

Andrea Robayo, Fundación Santa Fe de Bogotá

Medicine Faculty, Universidad de los Andes, Hospital Universitario Fundación Santa Fe de Bogotá (Bogotá, Colombia).

Marcela Mejía, Fundación Santa Fe de Bogotá

Laboratory and Pathology Department, Fundación Santa Fe de Bogotá (Bogotá, Colombia).

Andrés Felipe Cardona, Fundación Santa Fe de Bogotá

Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Foundation for Clinical and Applied Cancer Research (FICMAC); associated researcher ONCOLGroup.

Henry Becerra, Fundación Santa Fe de Bogotá

Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia).

Jorge Miguel Otero, Fundación Santa Fe de Bogotá

Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Foundation for Clinical and Applied Cancer Research (FICMAC); associated researcher ONCOLGroup.

Hernán Carranza, Fundación Santa Fe de Bogotá

Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Foundation for Clinical and Applied Cancer Research (FICMAC); associated researcher ONCOLGroup.

Carlos Vargas, Fundación Santa Fe de Bogotá

Clinical and Translational Oncology Group, Institute of Oncology, Fundación Santa Fe de Bogotá (Bogotá, Colombia). Foundation for Clinical and Applied Cancer Research (FICMAC); associated researcher ONCOLGroup.

Javier Carrera, Fundación Santa Fe de Bogotá

Colon and Rectal Surgery Department, Fundación Santa Fe de Bogotá (Bogotá, Colombia).